meditherapy Adapinoid Core Spot Treatment 30ml

Description

Meditherapy Adapinoid Core Spot Treatment is a 30 mL spot treatment from the brand’s Core Line. It targets hard, recurring blemishes caused by sebum and similar factors, the kind that often show up around the chin. A high concentration of Adapinoid works on the blemish root, meaning the skin environment where trouble begins, within the stratum corneum. A patented soothing ingredient calms the skin quickly. It is a gentle, non-comedogenic choice for acne-prone skin that needs fast spot care.

Why This One

• 3,000 ppm Adapinoid paired with 20,000 ppm Derma-Clera, a targeted dual-ingredient formula built for stubborn spots.
• Visible improvement in just 6 hours in a human application test of 21 adult men and women, so you can count on it when a breakout appears before an important day.
• Non-comedogenic tested at P&K Skin Clinical Research Center with 22 adults, giving acne-prone skin a formula that does not clog pores.

Key Features

• Deep: high-concentration Adapinoid works down to the blemish root, limited to the stratum corneum.
• Fast: delivers SOS soothing with a patented ingredient, calming the blemish root in 6 hours.
• Comfortable: gentle on skin, working at a pace your skin can accept without irritation worries.
• Designed for hard, deep-seated blemishes that are difficult to extract and tend to return in the same spot.
• Non-comedogenic and suitable for acne-prone skin.
• Part of the Meditherapy Core Line trouble-care range.

Key Ingredients

• Adapinoid (3,000 ppm): a next-generation ingredient that cares for the blemish root. It absorbs slowly, at a speed the skin can accept.
• Derma-Clera (20,000 ppm): a patented ingredient, application No. 2009-0075347, proven effective at relieving skin irritation. It interrupts irritation signals (nitric oxide) within the skin and stabilizes skin condition.

Clinical Testing

• Skin soothing: human application test of Adapinoid Core Spot Treatment and one other product, Korea Institute of Dermatological Sciences, 2026.05.26 to 2026.06.02, 21 adult men and women. Visible improvement was seen in just 6 hours.
• Non-comedogenicity: human application test for suitability on acne-prone skin, P&K Skin Clinical Research Center, 2026.04.20 to 2026.05.19, 22 adults. Results are based on combined use of four Core Line products:
  • Totarol Core Booster Spray Serum
  • Adapinoid Core Booster Serum
  • Panthenol Core Booster Cream
  • Adapinoid Core Spot Treatment

Specifications

Cautions

• This is a cosmetic product, not a medicine.
• Individual results may vary.